Persistent back pain lasting over three months, often with no identifiable physical cause in 85% of cases. The NIH reports that chronic back pain affects over 25 million U.S. adults, with PRT showing a 66% pain-free rate in a 2021 trial, making it a leading treatment for neuroplastic back pain.